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In the ﬁght against cancer (Pinedo and Giaccone, 1998), drug
resistance is the major barrier. The resistance against drug can
be acquired by the over-expression of anti-apoptotic Bcl-2 pro-
teins protecting cancer cells from apoptosis (Xing et al., 2007).
Bcl-2 is the prototype for a family of mammalian genes and the
proteins they produce. They govern mitochondrial outer mem-
brane permeabilization (MOMP) and can be either pro-apop-
totic (Bax, BAD, Bak and Bok among others) or anti-
apoptotic (including Bcl-2 proper, Bcl-XL, and Bcl-w among
an assortment of others). Bcl-2 derives its name from B-Cell
Lymphoma 2, as it is the second member of a range of proteins
initially described as a reciprocal gene translocation in chro-
mosomes 14 and 18 in follicular lymphomas.il.com (A.K. Srivastava).
ity.
lsevierThe members of the Bcl-2 family share one or more of the
four characteristic domains of homology entitled the Bcl-2
homology (BH) domains (named BH1, BH2, BH3 and BH4).
The BH domains are known to be crucial for function such
as deletion of these domains via molecular cloning affects
and survival/apoptosis rates.
The Bcl-2 gene has been implicated in a number of cancers,
including melanoma, breast, prostate, and lung carcinomas as
well as schizophrenia and autoimmunity. It is also thought to
be involved in resistance to conventional cancer treatment.
This supports a role for decreased apoptosis in the pathogen-
esis of cancer. Bcl-w is a member of the Bcl-2 family of pro-
teins. It is being referred to also as Bcl-2-like-2 (abbr.
BCL2L2). The Bcl-w protein (193 amino acids) expressed in
a wide variety of tissues is functionally similar to Bcl-2 and
promotes survival of cells against stimuli initiating cell death
by apoptosis.2. Methodology
The QSAR analysis was performed on the Bcl-2 protein inhib-
itor analogues using different structural parameters and some
indicator variables. Molar refractivity (MR) (ACD Labs
Software, XXX), was calculated by ACD Lab Chem Sketch
260 A.K. Srivastava et al.Software, while topological descriptors ﬁfth order of molecular
connectivity (5v) (DRAGON Software, XXX), mean wiener
index (WA) (DRAGON Software, XXX) and Balaban dis-
tance connectivity index (J) (DRAGON Software, XXX) were
calculated by using Dragon Software and information theo-
retic index (Id) was evaluated by Lucic and Trinajstic
(1999a,b). The indicator parameters I1 for C(O)OH(CH2)2
and I2 for (CH3)2CHCH2 at R1 position were used. Regression
analysis was performed by using SPSS 7.5 version.3. Results and discussion
The set of 15 compounds used along with their activities and
calculated physiochemical parameters are given in Table 1.
The mutual correlation of parameters and indicators with
activity are given in Table 2. The best triparametric models
generated for the series are given below along with the statisti-
cal data.
pIC50 ¼0:734ð0:746ÞJ 0:655ð0:638ÞI1 0:635ð0:354ÞI2
þ 5:303n¼ 15; R¼ 0:855; R2 ¼ 0:731; R2A ¼ 0:657;
SE¼ 0:263; Fð3;11Þ ¼ 9:940; Q¼ 3:250 ð1Þ
In the above QSAR model, n is the number of data points,
R is the correlation coefﬁcient, R2 is the coefﬁcient of determi-
nation, R2A is the adjusted R
2, SE is the standard error of esti-
mate, F is the variance ratio (Diudea, 2000; Bikash et al., 2003)
andQ is the quality of ﬁt (Pogliani, 1994, 1996). For all the sta-
tistical terms model (1) show the satisfactory values is statisti-
cally signiﬁcant. Values of R and R2 are not so good but
improve, when we tried some triparametric models as given
below.Table 1 Biological activity and physicochemical data for Bcl-2 pro
R3
R
S. no. R1 R2 R3 R4 J
1 2-Propyl H Br OH 1
2 Me H Br OH 1
3 CH3S(CH2)2 H Br OH 1
4 3-Indolyl-CH2 H Br OH 1
5 C(O)OH(CH2)2 H Br OH 1
6 PhCH2 H Br OH 1
7 PhCH2 n-Propyl H OH 1
8 (CH3)2CH2CH2 H Br OH 1
9 (CH3)2CH2CH2 n-Propyl H OH 2
10 (CH3)2CH2CH2 Me H OH 2
11 (CH3)2CH2CH2 Ph H OH 1
12 (CH3)2CH2CH2 Ph Ph OH 1
13 Me H Br N-morpholinyl 1
14 PhCH2 H Br O-2-propenyl 1
15 PhCH2 H Ar O-2-propenyl 1pIC50 ¼ 0:360ð0:277ÞWA 0:778ð0:553ÞI1
þ 0:558ð0:296ÞI2þ 2:163
n¼ 15; R¼ 0:883; R2 ¼ 0:780; R2A ¼ 0:720; SE¼ 0:237;
Fð3;11Þ ¼ 12:974; Q¼ 3:725 ð2Þ
pIC50 ¼ 0:994ð0:691ÞId 0:791ð0:528ÞI1
þ 0:464ð0:280ÞI2 0:557
n¼ 15; R¼ 0:894; R2 ¼ 0:799; R2A ¼ 0:744; SE¼ 0:227;
Fð3;11Þ ¼ 14:585; Q¼ 3:938 ð3Þ
pIC50 ¼ 0:013ð0:009ÞMR 0:652ð0:532ÞI1
þ 0:474ð0:274ÞI2þ 2:572
n¼ 15; R¼ 0:898; R2 ¼ 0:806; R2A ¼ 0:754; SE¼ 0:222;
Fð3;11Þ ¼ 15:270; Q¼ 4:045 ð4Þ
pIC50 ¼ 0:169ð0:107Þ5v 0:692ð0:511ÞI1
þ 0:407ð0:271ÞI2þ 3:049
n¼ 15; R¼ 0:904; R2 ¼ 0:817; R2A ¼ 0:767; SE¼ 0:216;
Fð3;11Þ ¼ 16:370; Q¼ 4:185 ð5Þ
On a close study of (2)–(5) we ﬁnd an increase in the values
of all the statistical terms, model (5) is found to be the best re-
gressed model. The coefﬁcient of 5v is positive in model no. (5)
meaning thereby, that increase in ﬁfth order connectivity is
favorable for the activity. The statistical details of the QSAR
model given above speak for its good statistical quality. Low
value of standard error of estimate (<0.3) indicates the accu-
racy of the statistical ﬁt. The F-statistic for the best model (5) is
16.370 (compared to the critical value of 3.59 at the 0.05 level
of signiﬁcance).
The positive sign of coefﬁcient of WA, Id and MR in model
nos. (2)–(4), respectively, indicate that the steric factor seems
to be more dominating towards the activity and the group
having more vertices is favorable for the activity. Whereastein inhibitor analogues.
2
N
S
O
S
R1
R4 O
WA Id MR 5v I1 I2 pIC50
.982 4.623 4.401 94.51 4.777 0 0 3.906
.905 4.421 4.383 85.27 4.147 0 0 3.614
.944 4.913 4.482 102.55 5.002 0 0 4.055
.386 5.655 4.827 121.47 7.456 0 0 4.266
.953 5.076 4.591 96.19 5.082 1 0 3.214
.594 5.308 4.671 109.99 6.198 0 0 4.214
.712 5.270 4.779 115.93 6.841 0 0 4.386
.973 4.834 4.464 99.14 5.195 0 1 4.505
.153 4.790 4.591 105.09 5.837 0 1 4.617
.076 4.605 4.464 95.82 5.170 0 1 4.234
.810 5.013 4.767 115.91 7.127 0 1 4.208
.484 6.057 5.049 140.61 8.899 0 1 5.156
.559 5.243 4.554 105.85 5.629 0 0 3.835
.658 5.613 4.769 123.63 6.531 0 0 4.245
.615 6.110 4.869 129.56 6.848 0 0 3.935
Table 2 Correlation matrix between biological activity and physicochemical parameters and indicator variables.
A J WA Id MR 5v I1 I2
A 1.000
J 0.208 1.000
WA 0.339 0.815 1.000
Id 0.508 0.730 0.906 1.000
MR 0.589 0.733 0.930 0.964 1.000
5v 0.657 0.713 0.830 0.967 0.949 1.000
I1 0.582 0.198 0.050 0.075 0.244 0.215 1.000
I2 0.627 0.355 0.156 0.086 0.092 0.233 0.189 1.000
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that [C(O)OH(CH2)2] group should be avoided in future drug
modeling and positive sign of coefﬁcient of indicator parame-
ter I2 shows that [(CH3)2CHCH2] group is beneﬁcial towards
the anti-apoptotic activity. On the basis of this statement it
is clear that [(CH3)2CHCH2] should be retained at R1 position
in future drug designing.
All above equations suggest that substituents having more
branching, bulkier and those having more vertices should be
used in further drug development.
3.1. Cross validation
The cross validation analysis was performed using leave one
out (LOO) method (Cramer et al., 1988; Podlgar and Fergu-
son, 2000), in which one compound is removed from the data
set and the activity is correlated using the rest of the data set.
The cross-validated R2 in each case was found to be very closeTable 4 Values of predictive error of coefﬁcient of correlation and
S. no. Model no. Parameter used N R 1  R2 PE
1 1 J+ I1 + I2 15 0.855 0.268 0.0
2 2 WA+ I1 + I2 15 0.883 0.220 0.0
3 3 Id + I1 + I2 15 0.894 0.200 0.0
4 4 MR+ I1 + I2 15 0.898 0.193 0.0
5 5 5v+ I1 + I2 15 0.904 0.182 0.0
Table 3 Comparison between observed and predicted activ-
ities and their residual values.
S. no. pIC50 Pred. Resi.
1 3.906 3.855 0.051
2 3.614 3.749 0.135
3 4.055 3.893 0.162
4 4.266 4.307 0.041
5 3.214 3.214 0.000
6 4.214 4.095 0.119
7 4.386 4.203 0.183
8 4.505 4.333 0.172
9 4.617 4.441 0.176
10 4.234 4.329 0.095
11 4.208 4.659 0.451
12 5.156 4.958 0.198
13 3.835 3.999 0.164
14 4.245 4.151 0.094
15 3.935 4.204 .269to the value of R2 for the entire data set and hence these mod-
els can be termed as statistically signiﬁcant.
Cross validation provides the values of PRESS, SSY and
R2cv and PSE from which we can test the predictive power of
the proposed model. It is argued that PRESS, is a good esti-
mate of the real predictive error of the model and if it is smaller
than SSY the model predicts better than chance and can be
considered statistically signiﬁcant. Furthermore, the ratio
PRESS/SSY can be used to calculate approximate conﬁdence
intervals of prediction of new compound. To be a reasonable
QSAR model PRESS/SSY should be smaller than 0.4. Also,
if PRESS value is transformed in a dimension less term by
relating it to the initial sum of squares, we obtain R2cv i.e. the
complement to the traces on of unexplained variance over
the total variance. The PRESS and R2cv have good properties.
However, for practical purposes of end users the use of square
root of PRESS/N, which is called predictive square error
(PSE), is more directly related to the uncertainty of the predic-
tions. The PSE values also support our results. The calculated
cross-validated parameters conﬁrm the validity of the models.
All the requirements for an ideal model have been fulﬁlled by
model no. (5), that is why, we have considered as the best
model.
R2A takes into account the adjustment of R
2. R2A is a measure
of the percentage explained variation in the dependent variable
that takes into account the relationship between the number of
cases and the number of independent variables in the regres-
sion model, whereas R2 will always increase when an indepen-
dent variable is added. R2A will decrease if the added variable
does not reduce the unexplained variable enough to offset
the loss of decrease of freedom.
3.2. Predictive error of coefﬁcient of correlation (PE)
The predictive error of coefﬁcient of correlation (PE) (Chatter-
jee et al., 2000) is yet another parameter used to decide the pre-
dictive power of the proposed models. We have calculated PE
value of all the proposed models and they are reported in
Table 4. It is argued that ofcross validation parameters of Bcl-2 protein inhibitor analogues.
6PE PRESS SSY PRESS/SSY R2cv PSE
46 0.276 0.761 2.063 0.368 0.632 0.225
37 0.224 0.622 2.202 0.282 0.718 0.203
34 0.204 0.567 2.257 0.251 0.749 0.194
32 0.196 0.547 2.277 0.240 0.460 0.190
30 0.184 0.517 2.308 0.224 0.776 0.185
Figure 1 A plot showing comparison between observed and
predicted pIC50 values using model no. (5).
262 A.K. Srivastava et al.(i) R< PE, then correlation is not signiﬁcant;
(ii) R> PE; several times (at least three times), then corre-
lation is indicated; and if
(iii) R> 6PE, then the correlation is deﬁnitely good.
For all the models developed the condition R> 6PE is sat-
isﬁed and hence they can be said to have a good predictive
power.
Predicted and residual activity values for model no. (5) are
given in Table 3. Predicted values are the calculated activities
obtained from model no. (5) and the residual values are the dif-
ference between the observed biological activities and calcu-
lated activities
In order to examine the relative potential of the proposed
models, we have further estimated their predictive correlation
coefﬁcients (R2 pred) by plotting graph between observed
and calculated pIC50 values using model no. (5). Such correla-tion is shown in Fig. 1. The values of R2 pred. determined by
using model no. (5) came out to be 0.817 thus conﬁrming our
ﬁndings.4. Conclusions
On the basis of the discussion following conclusions are drawn:
1. Bulkier groups having more branching should be used.
2. More polar groups are favorable for the activity.
3. Among all the given parameters 5v plays a dominant role
with indicator variable I2.
4. [(CH3)2CHCH2] group should be retained at R1-position.
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